TTK Healthcare
Ttk Healthcare Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in TTK Healthcare
Start SIPTtk Healthcare Investment Rating
-
Master Rating:
-
T T K Healthcare (Nse) has an operating revenue of Rs. 725.11 Cr. on a trailing 12-month basis. An annual revenue growth of 26% is outstanding, Pre-tax margin of 9% is okay, ROE of 67% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 24% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 180 | 183 | 170 | 193 | 159 |
| Operating Expenses Qtr Cr | 165 | 174 | 166 | 189 | 154 |
| Operating Profit Qtr Cr | 15 | 8 | 4 | 4 | 5 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 | 3 |
| Interest Qtr Cr | 1 | 1 | 1 | 3 | 1 |
| Tax Qtr Cr | 6 | 4 | 3 | 3 | 2 |
| Net Profit Qtr Cr | 17 | 12 | 10 | 601 | 11 |
Ttk Healthcare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 12
- Bearish Moving Average
- ___
- 4
- 20 Day
- ₹1254.33
- 50 Day
- ₹1207.5
- 100 Day
- ₹1131.53
- 200 Day
- ₹1035.11
- 20 Day
- ₹1251.25
- 50 Day
- ₹1243.8
- 100 Day
- ₹1092.23
- 200 Day
- ₹1012.09
Ttk Healthcare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹1271.62 |
| Second Resistance | ₹1284.74 |
| Third Resistance | ₹1292.47 |
| RSI | 55.52 |
| MFI | 64.72 |
| MACD Single Line | 14.79 |
| MACD | 12.02 |
| Support | |
|---|---|
| First Resistance | ₹1250.77 |
| Second Resistance | ₹1243.04 |
| Third Resistance | ₹1229.92 |
Ttk Healthcare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 15,662 | 1,088,039 | 69.47 |
| Week | 25,558 | 1,606,320 | 62.85 |
| 1 Month | 33,268 | 1,942,843 | 58.4 |
| 6 Month | 35,564 | 1,547,405 | 43.51 |
Ttk Healthcare Result Highlights
TTK Healthcare Synopsis
NSE-Medical-Diversified
Ttk Healthcare Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 725.11 Cr. and Equity Capital is Rs. 14.13 Cr. for the Year ended 31/03/2023. TTK Healthcare Ltd. is a Public Limited Listed company incorporated on 21/05/1958 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1958PLC003647 and registration number is 003647.| Market Cap | 1,778 |
| Sales | 725 |
| Shares in Float | 0.35 |
| No of funds | 23 |
| Yield | 0.79 |
| Book Value | 1.87 |
| U/D Vol ratio | 1.8 |
| LTDebt / Equity | |
| Alpha | 0.23 |
| Beta | 0.64 |
TTK Healthcare
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 74.56% | 74.56% | 74.56% | 74.56% |
| Mutual Funds | 2.98% | 2.17% | 2.21% | 2.5% |
| Foreign Portfolio Investors | 2.38% | 2.32% | 2.37% | |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
| Individual Investors | 16.73% | 15.49% | 14.97% | 15.19% |
| Others | 3.34% | 5.45% | 5.88% | 7.74% |
TTK Healthcare Management
| Name | Designation |
|---|---|
| Mr. T T Jagannathan | Chairman |
| Mr. T T Raghunathan | Executive Vice Chairman |
| Mr. R K Tulshan | Director |
| Mr. K Shankaran | Director |
| Dr.(Mrs.) Vandana R Walvekar | Director |
| Mr. Girish Rao | Director |
| Mr. S Balasubramanian | Director |
| Mr. N Ramesh Rajan | Director |
| Mr. V Ranganathan | Director |
| Mr. S Kalyanaraman | Whole Time Director |
Ttk Healthcare Forecast
Price Estimates
Ttk Healthcare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-23 | Audited Results & Final Dividend | |
| 2023-04-20 | Voluntary Delisting of shares | |
| 2023-02-07 | Quarterly Results | |
| 2022-10-28 | Quarterly Results | |
| 2022-07-26 | Quarterly Results |
TTK Healthcare FAQs
What is Share Price of TTK Healthcare ?
TTK Healthcare share price is ₹1260 As on 10 June, 2023 | 16:03
What is the Market Cap of TTK Healthcare ?
The Market Cap of TTK Healthcare is ₹1780.4 Cr As on 10 June, 2023 | 16:03
What is the P/E ratio of TTK Healthcare ?
The P/E ratio of TTK Healthcare is 2.8 As on 10 June, 2023 | 16:03
What is the PB ratio of TTK Healthcare ?
The PB ratio of TTK Healthcare is 1.9 As on 10 June, 2023 | 16:03